Novocure Ltd
Haifa, Israel
Moshe Giladi, PhD, Senior VP of Preclinical Research, Novocure Ltd.
Novocure, Ltd. - an R&D company developing a new physical anti-cancer treatment modality based on alternating electric fields.
Moshe joined Novocure in 2009 and leads the preclinical development overseeing all preclinical activities and external research collaborations. Prior to Novocure, Moshe worked at NovoBiotic, a spin-off company of Novocure focused on treatment against infectious diseases.
Moshe received a BS in Biology, MS in Microbiology and Entomology and Ph. D. in Molecular Microbiology and Biotechnology from Tel Aviv University. Moshe also holds his MBA from Tel Aviv University.